Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Baclofen destabilises breathing during sleep in healthy humans: A randomised, controlled, double‐blind crossover trial.

Tytuł:
Baclofen destabilises breathing during sleep in healthy humans: A randomised, controlled, double‐blind crossover trial.
Autorzy:
Straus, Christian (AUTHOR)
Teulier, Marion (AUTHOR)
Morel, Sébastien (AUTHOR)
Wattiez, Nicolas (AUTHOR)
Hajage, David (AUTHOR)
Giboin, Caroline (AUTHOR)
Charbit, Beny (AUTHOR)
Dasque, Eric (AUTHOR)
Bodineau, Laurence (AUTHOR)
Chenuel, Bruno (AUTHOR)
Straus, Nicolas (AUTHOR)
Attali, Valérie (AUTHOR)
Similowski, Thomas (AUTHOR)
Temat:
CROSSOVER trials
CENTRAL pattern generators
BACLOFEN
NON-REM sleep
RESPIRATION
RAPID eye movement sleep
SLEEP
Źródło:
British Journal of Clinical Pharmacology. Apr2021, Vol. 87 Issue 4, p1814-1823. 10p.
Czasopismo naukowe
Aims: Periodic breathing is frequent in patients with severe heart failure. Apart from being an indicator of severity, periodic breathing has its own deleterious consequences (sleep‐related oxygen desaturations, sleep fragmentation), which justifies attempts to correct it irrespective of the underlying disease. Animal models and human data suggest that baclofen can reconfigure respiratory central pattern generators. We hypothesised that baclofen, a GABAB agonist, may thus be able to correct periodic breathing in humans. Methods: Healthy volunteers were exposed to hypoxia during sleep. Participants who developed periodic breathing (n = 14 [53 screened]) were randomly assigned to double‐blind oral baclofen (progressively increased to 60 mg/d) or placebo. The primary outcome was the coefficient of variation (CoVar) of respiratory cycle total time considered as an indicator of breathing irregularity. Secondary outcomes included the CoVar of tidal volume, apnoea–hypopnoea index, sleep fragmentation index and ventilatory complexity (noise limit). Results: The analysis was conducted in 9 subjects after exclusion of incomplete datasets. CoVar of respiratory cycle total time significantly increased with baclofen during non‐rapid eye movement sleep (median with placebo 56.00% [37.63–78.95]; baclofen 85.42% [68.37–86.40], P =.020; significant difference during the N1‐N2 phases of sleep but not during the N3 phase). CoVar of tidal volume significantly increased during N1‐N2 sleep. The apnoea–hypopnoea index, sleep fragmentation index and ventilatory complexity were not significantly different between placebo and baclofen. Conclusion: Baclofen did not stabilise breathing in our model. On the contrary, it increased respiratory variability. Baclofen should probably not be used in patients with or at risk of periodic breathing. [ABSTRACT FROM AUTHOR]
Copyright of British Journal of Clinical Pharmacology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies